• Computer Aided Drug Design
• Cancer Biology
• Medicinal Chemistry
• Ph.D. (Pharmaceutical Chemistry- 2022)- Jamia Hamdard
• M.Pharm (Pharmaceutical Chemistry- 2014-2016)- Jamia Hamdard
Important Research Publications:
• Pathak A, Pandey V, Raj Pokharel Y, Devaraji V, Ali A, Haider K, Saad S, Dewangan RP, Siddiqui N, Shahar Yar M. Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents, Bioorg Chem. 2021,105358.
• Nehal N, Nabi B, Rehman S, Pathak A, Iqubal A, Khan SA, Yar MS, Parvez S, Baboota S, Ali J. Chitosan coated synergistically engineered nanoemulsion of Ropinirole and nigella oil in the management of Parkinson’s disease: Formulation perspective and In vitro and In vivo assessment. Int J Biol Macromol, 2021, 167:605-619.
• Shahi N, Pandey V, Pathak A et al, Anticancer potential of 3-hydroxypyridine-2-carboxaldehyde N(4)-methyl and pyrrolidinylthiosemicarbazones and their Zn(II) complexes in different cancers via targeting MAPK superfamily signaling pathway, Results in Chemistry, 3, 2021, 100104.
Important Review Publications:
• Pathak A, Rohilla A, Gupta T, Akhtar MJ, Haider MR, Sharma K, Haider K, Yar MS. DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective. Eur J Med Chem. 2018 Oct 5;158:559-592.
• Shaikh Yahya, Kashif Haider, Ankita Pathak, Akram Choudhary, Pooja Hooda, Mohd Shafeeq, Mohammad Shahar Yar, Strategies in synthetic design and structure–activity relationship studies of novel heterocyclic scaffolds as aldose reductase‐2 inhibitors, Archiv der Pharmazie, 2022.
• Neha K, Haider MR, Pathak A, Yar MS. Medicinal prospects of antioxidants: A review. Eur J Med Chem. 2019 Sep 15;178:687-704.
• Haider K, Pathak A, Rohilla A, Haider MR, Ahmad K, Yar MS. Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review. Eur J Med Chem. 2019 Dec 15;184:111773.
Conference Papers:
• Aniyery R B, Gupta A, Pathak A, Kaur H. Anticancer and Antimicrobial studies of Stannane of D Biotin, SPAST Abstracts, 2021.
Important Paper Presentation (National & International)
• Ankita Pathak, speaker, 9th World Congress on ” Pharmaceutical Research and Drug Discovery, Cricket Field Road Uxbridge, Midadlesex, UB8 1QG, UK, International Conference, 27-28-July-2022.
• “Innovations in Quality by Design (QbD) and Its Implementation in Pharmaceutical Industry”, FDP, School of Pharmacy, Chitkara University, Himachal Pradesh, 27 June-02-July-2022.
• Ankita Pathak, M. Shahar Yar, Oral presentation on Computational drug design and synthesis of pharmacophore based hybrid oncological molecules, Indian Pharmaceutical Association Annual Convention (IPAC 2021) on Reimaging pharmacy in the 21st century: Transformational change ahead, held during July 16 and 17, 2021, The Indian Pharmaceutical Association (IPA) Anantapur.
• Ankita Pathak, M. Shahar Yar, “The Pharmacophore development of oxindole based derivatives as anit-angiogenic agents”, 7th International Congress of Society for Ethnopharmacology, Jamia Hamdard, New Delhi, India, February 15-17th, 2020,.
• Ankita Pathak, M. Shahar Yar “Structural insights of VEGFR-2 governing selectivity of Type II dual kinase inhibitors with remarkable anti-angiogenic profile” (Abstract Refrence Number- CHAL2019_0068), cell symposia: Halmarks of cancer, 2019.
• Ankita Pathak, Dr. M. Shahar Yar, Pharmacophore based drug design and synthesis of oncological hybrid inhibitors, Innopharm3: 3rd International Conference on Academic and Industrial Innovations, 22-23 Oct, 2018.
Patents
• Gupta A, Aniyery R B, Pathak A, Kaur H., “Antimicrobial, antifungal and anticancer activity of N-(5-(N-((Z)-2-((Z)-(((5-acetamido-1,3,4-thiadiazol-2-yl)sulfonyl)imino)methyl)-6-methoxyphenoxy)dibutylstannyl)oxy)-3-methoxybenzylidene)sulfamoyl)-1,3,4-thiadiazol-2-yl)acetamide,” Provisional Patent Application No 202111013358.
Workshops
Hands-on training, Schrodinger, JHU, 2018
• High Impact Factor Paper Award
First author Ph.D. research paper award for high impact factor (IP: 5.27) on science day at Jamia Hamdard.
• Awarded with ICMR-SRF fellowship by ICMR
Study of Cancer based mechanisms and design of anti-cancer molecules by CADD
• Best Poster Award
M.Pharm, Jamia Hamdard